新里程(002219.SZ):在目前全面推行DRG/DIP改革的情況下,公司醫療服務板塊淨利率仍達到了近10%的水平
格隆匯9月30日丨新里程(002219.SZ)在投資者關係活動上表示,DRG/DIP改革對所有醫療機構都有根本性影響,極大地改變和重構了臨牀行為,不只是簡單付費層面的影響。隨着DRG/DIP改革,精細化管理成為醫院的核心競爭力之一。公司主要通過以下三個方面加以應對:一、每家醫院成立專門的醫保管理工作小組,用醫保支付政策來指導臨牀診療行為,圍繞醫保政策進行學科規劃和學科設置並指導科室經營。二、提高醫保管理精細化水平,大幅控制藥耗佔比。三、加強內涵建設,大力發展手術科室學科實力,提高CMI值。公司主動擁抱醫保改革,從上半年經營數據來看,實施DRG的醫院全部實現了醫保結餘,實施DIP的醫院通過精細化管理大面積解決了科室虧損,在目前全面推行DRG/DIP改革的情況下,公司醫療服務板塊淨利率仍達到了近10%的水平。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.